U.S. Senate Passes Historic Gerald E. Connolly Esophageal Cancer Awareness Act
First stand-alone federal legislation focused exclusively on esophageal cancer heads to President Trump’s desk Washington, DC — May 22, [...]
First stand-alone federal legislation focused exclusively on esophageal cancer heads to President Trump’s desk Washington, DC — May 22, [...]
Experienced Nonprofit Leader Succeeds Retiring Founder Mindy Mintz Mordecai (BALTIMORE, MD—February 11, 2026) — The Esophageal Cancer Action Network [...]
In his final official act before Esophageal Cancer cut short his life, Congressman Gerald Connolly (D-Va) made history by [...]
As a shutdown deadline loomed, members of the US House and Senate voted to pass a budget plan crafted [...]
The Food and Drug Administration (FDA) has approved Zolbetuximab (Vyloy) as a first-line treatment for patients with advanced HER2* [...]
A German study finds a 30% reduction in the risk of death among Esophageal Adenocarcinoma patients who were treated [...]
In 2021, Esophageal Cancer patients and advocates celebrated the Food and Drug Administration’s approval of immunotherapies for patients with [...]
DEADLINE FAST APPROACHING! Join ECAN on Capitol Hill in June as we advocate to end Esophageal Cancer with our [...]
A newly released study of the benefits of the EsoGuard® Esophageal DNA test says it is a powerful screening [...]
“Our best treatment for Esophageal Cancer is preventing Esophageal Cancer.” ~ Dr. John C. Lipham, M.D. Chair, ECAN Board [...]